Actively personalized cancer vaccines – The step into the clinical application

Author： Kloke Björn-Philipp Kreiter Sebastian Diken Mustafa Sahin Ugur

ISSN： 2195-2175

Source： PHARMAKON, Vol.3, Iss.4, 2015-07, pp. : 304-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Actively personalized cancer vaccines – the step into clinical application

By Kloke B.-P. Kreiter S. Vormehr M. Diken M. Kuhn A. N. Sahin U.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 71, Iss. 1, 2016-01 ,pp. : 43-47

Govi-Verlag

Access to resources Recommend Favorite

Clinical Pharmacogenetics and Potential Application in Personalized Medicine

Current Drug Metabolism, Vol. 9, Iss. 8, 2008-10 ,pp. : 738-784

Bentham Science Publishers

Access to resources Recommend Favorite

Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer vaccines entering Phase III clinical trials

By Durrant LG Spendlove I

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Cancer vaccines

By Bonnefoy Jean-Yves

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 521-525

Informa Healthcare

Access to resources Recommend Favorite